Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Knoll GA – In proteinuric transplant recipients, treatment with an angiotensin–converting enzyme inhibitor or angiotensin receptor blocker can decrease proteinuria, but there is no evidence from randomized trials that this strategy improves patient or graft survival. This review focuses on the measurement, prevalence, pathological findings, prognostic significance, and evidence–based management of proteinuria in kidney transplant recipients.

Related Articles

The Alphabet Soup of Kidney Transplantation: SCD, DCD, ECD—Fundamentals for the Practicing Nephrologist
Clinical Journal of the American Society of Nephrology, 11/16/09    Relevance Score: 70%

The Evolution of Kidney Function After Lung Transplantation: A Retrospective Cohort Study
Transplantation Proceedings, 11/11/09    Relevance Score: 70%

ABO-Incompatible Kidney Transplantation
Transplantation, 10/29/09    Relevance Score: 70%

Ethical Issues and Living Unrelated Donor Kidney Transplantation
Iranian Journal of Kidney Diseases, 10/13/09    Relevance Score: 69%

The Science of Stewardship: Due Diligence for Kidney Donors and Kidney Function in Living Kidney Donation—Evaluation, Determinants, and Implications for Outcomes
Clinical Journal of the American Society of Nephrology, 10/08/09    Relevance Score: 69%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address